Zacks Investment Research on MSN
Agios Pharmaceuticals stock declines 23% in 6 months: Here's why
Shares of Agios Pharmaceuticals AGIO have plunged 23% over the past six months, primarily due to pipeline and regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results